By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted January 10, 2022APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 REVENUE RESULTS READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted November 11, 2021APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOK READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted November 10, 2021APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBER READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted October 4, 2021APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON NOVEMBER 11, 2021 READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted August 30, 2021APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF WENDY LEVINE TO THE COMPANY’S BOARD OF DIRECTORS READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted August 12, 2021APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOK READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted July 12, 2021APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON AUGUST 12, 2021 READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted June 3, 2021APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCE READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted June 1, 2021APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted May 12, 2021APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOK READ MORE
